Metzger ML, Link MP, Billett AL, Flerlage J, et al. Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation. J Clin Oncol 2021 Apr 7:JCO2003286. doi: 10.1200/JCO.20.03286.
PMID: 33826362